MUTYH-associated polyposis

Best Practice and Research: Clinical Gastroenterology

Volumn 23, Issue 2, 2009, Pages 209-218

  Sampson, Julian R ^a   Jones, Natalie ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

colorectal cancer; duodenal adenomas; duodenal cancer; MAP; multiple colorectal adenomas; MUTYH

Indexed keywords

APC PROTEIN; DNA GLYCOSYLASE MUTY;

ADENOMATOUS POLYP; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BREAST CANCER; CANCER RISK; CLINICAL FEATURE; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL SURGERY; DISEASE SURVEILLANCE; DUODENUM CANCER; EPITHELIUM TUMOR; EXCISION REPAIR; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; MUTYH ASSOCIATED POLYPOSIS; PHENOTYPE; PREVALENCE; RISK FACTOR; SEBACEOUS GLAND TUMOR; STOMACH POLYP;

ADENOMATOUS POLYPOSIS COLI; ADULT; AGED; DNA GLYCOSYLASES; DNA MUTATIONAL ANALYSIS; EARLY DETECTION OF CANCER; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MIDDLE AGED; PATIENT SELECTION; PEDIGREE; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; YOUNG ADULT;

EID: 65349091904     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2009.03.006     Document Type: Article

References (63)

1. Al-Tassan N., Chmiel N.H., Maynard J., et al. Inherited variants of MYH associated with somatic G: C → T: a mutations in colorectal tumors. Nat Genet 30 (2002) 227-232
2. Jones S., Emmerson P., Maynard J., et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C → T:A mutations. Hum Mol Genet 11 (2002) 2961-2967
3. Sieber O.M., Lipton L., Crabtree M., et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348 (2003) 791-799
4. Sampson J.R., Dolwani S., Jones S., et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 362 (2003) 39-41
5. Kanter-Smoler G., Bjork J., Fritzell K., et al. Novel findings in Swedish patients with MYH-associated polyposis: mutation detection and clinical characterization. Clin Gastroenterol Hepatol 4 (2006) 499-506
6. Ponti G., Ponz de Leon M., Maffei S., et al. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet 68 (2005) 442-447
7. Kumar V.K.A., Gold J.A., Mallon E., et al. Sebaceous adenomas in an MYH associated polyposis patient of Indian (Gujarati) origin. Fam Cancer 7 (2008) 187-189
8. Barnetson R.A., Devlin L., Miller J., et al. Germline mutation prevalence in the base excision repair gene, MYH, in patients with endometrial cancer. Clin Genet 72 (2007) 551-555
9. Croitoru M.E., Cleary S.P., Di Nicola N., et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 96 (2004) 1631-1634
10. Fleischmann C., Peto J., Cheadle J., et al. Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer. Int J Cancer 109 (2004) 554-558
11. Wang L., Baudhuin L.M., Boardman L.A., et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 127 (2004) 9-16
12. Farrington S.M., Tenesa A., Barnetson R., et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 77 (2005) 112-119
13. Tenesa A., Campbell H., Barnetson R., et al. Association of MUTYH and colorectal cancer. Br J Cancer 95 (2006) 239-242
14. Jones S., Lambert S., Williams G.T., et al. Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas. Br J Cancer 90 (2004) 591-593
15. Lipton L., Halford S.E., Johnson V., et al. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res 63 (2003) 595-599
16. Lindahl T. Instability and decay of the primary structure of DNA. Nature 362 (1993) 709-715
17. Babbs C.F. Free radicals and the etiology of colon cancer. Free Radic Biol Med 8 (1990) 191-200
18. Ames B.N., and Gold L.S. Endogenous mutagens and the causes of aging and cancer. Mutat Res 250 (1991) 3-16
19. Huycke M.M., and Gaskins H.R. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) 229 (2004) 586-597
20. Bartsch H., Nair J., and Owen R.W. Exocyclic DNA adducts as oxidative stress markers in colon carcinogenesis: potential role of lipid peroxidation, dietary fat and antioxidants. Biol Chem 383 (2002) 915-921
21. Dallosso A.R., Dolwani S., Jones N., et al. Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3. Gut 57 (2008) 1252-1255
22. Halford S.E., Rowan A.J., Lipton L., et al. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol 162 (2003) 1545-1548
23. Enholm S., Hienonen T., Suomalainen A., et al. Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol 163 (2003) 827-832
24. Gismondi V., Meta M., Bonelli L., et al. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer 109 (2004) 680-684
25. Isidro G., Laranjeira F., Pires A., et al. Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas. Hum Mutat 24 (2004) 353-354
26. Aceto G., Cristina Curia M., Veschi S., et al. Mutations of APC and MYH in unrelated Italian patients with adenomatous polyposis coli. Hum Mutat 26 (2005) 394
27. Vandrovcová J., Štekrová J., Kebrdlová V., et al. Molecular analysis of the APC and MYH genes in Czech families affected by FAP or multiple adenomas: 13 novel mutations. Hum Mutat 23 (2004) 397
28. Miyaki M., Iijima T., Yamaguchi T., et al. Germline mutations of the MYH gene in Japanese patients with multiple colorectal adenomas. Mutat Res 578 (2005) 430-433
29. Kairupan C.F., Meldrum C.J., Crooks R., et al. Mutation analysis of the MYH gene in an Australian series of colorectal polyposis patients with or without germline APC mutations. Int J Cancer 116 (2005) 73-77
30. Nielsen M., Franken P.F., Reinards T.H., et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 42 (2005) e54
31. Aretz S., Uhlhaas S., Goergens H., et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 119 (2006) 807-814
32. Nielsen M., Joerink-van de Beld M.C., Jones N., et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients with MUTYH-associated polyposis. Gastroenterology 136 (2009) 471-476
33. Balaguer F., Castellvi-Bel S., Castells A., et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin Gastroenterol Hepatol 5 (2007) 379-387
34. Jones N. Molecular genetic and phenotypic characteristics of patients with adenomatous colorectal polyposis. PhD Thesis, Cardiff University; 2007.
35. Jo W.-S., Bandipalliam P., Shannon K.M., et al. Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol 3 (2005) 1022-1028
36. Bouguen G., Manfredi S., Blayau M., et al. Colorectal adenomatous polyposis associated with MYH mutations: genotype and phenotype characteristics. Dis Colon Rectum 50 (2007) 1612-1617
37. Russell A.M., Zhang J., Luz J., et al. Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients. Int J Cancer 118 (2006) 1937-1940
38. Lynch H.T., Boland C.R., Gong G., et al. Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 14 (2006) 390-402
39. Barrow E., Robinson L., Alduaij W., et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 75 (2009) 141-149
40. Sieber O.M., Segditsas S., Knudsen A.L., et al. Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation. Gut 55 (2006) 1440-1448
41. Galiatsatos P., and Foulkes W.D. Familial adenomatous polyposis. Am J Gastroenterol 101 (2006) 385-398
42. Cao Y., Pieretti M., Marshall J., et al. Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature. Am J Gastroenterol 97 (2002) 1822-1827
43. Mecklin J.-P., Aarino M., Läärä E., et al. Development of colorectal tumours in colonoscopic surveillance in Lynch syndrome. Gastroenterology 133 (2007) 1093-1098
44. Knudsen A.L., Bisgaard M.L., and Bülow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2 (2003) 43-55
45. Chow E., Lipton L., Lynch E., et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 131 (2006) 30-39
46. Croitoru M.E., Cleary S.P., Berk T., et al. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients. J Surg Oncol 95 (2007) 499-506
47. Boparai K.S., Dekker E., Van Eeden S., et al. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology 135 (2008) 2014-2018
48. Lejeune S., Guillemot F., Triboulet J.P., et al. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis. Hum Mutat 27 (2006) 1064
49. Olschwang S., Blanché H., de Moncuit C., et al. Similar colorectal cancer risk in patients with monoallelic and biallelic mutations in the MYH gene identified in a population with adenomatous polyposis. Genet Test 11 (2007) 315-320
50. Nielsen M., Poley J.W., Verhoef S., et al. Duodenal carcinoma in MUTYH-associated polyposis. J Clin Pathol 59 (2006) 1212-1215
51. South C.D., Hampel H., Comeras I., et al. The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst 100 (2008) 277-281
52. Ponti G., Venesio T., Losi L., et al. BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees. J Invest Dermatol 127 (2007) 1387-1391
53. Tricarico R., Bet P., Ciambotti B., et al. Endometrial cancer and somatic G > T KRAS transversion in patients with constitutional MUTYH biallelic mutations. Cancer Lett 274 (2009) 266-270
54. Parker A.R., Sieber O.M., Shi C., et al. Cells with pathogenic biallelic mutations in the human MUTYH gene are defective in DNA damage binding and repair. Carcinogenesis 26 (2005) 2010-2018
55. Raoof M., Canter R.J., and Paty P.B. Variable phenotypic expression of identical MYH germline mutations in siblings with attenuated familial adenomatous polyposis. Am Surg 73 (2007) 1250-1253
56. Crabtree M.D., Tomlinson I.P.M., Hodgson S.V., et al. Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes. Gut 51 (2002) 420-423
57. Kambara T., Whitehall V.L., Spring K.J., et al. Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer 40 (2004) 1-9
58. Webb E.L., Rudd M.F., and Houlston R.S. Colorectal cancer risk in monoallelic carriers of MYH variants. Am J Hum Genet 79 (2006) 768-771
59. Zhou X.-L., Djureinovic T., Werelius B., et al. Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer. Genet Test 9 (2005) 147-151
60. Küry S., Buecher B., Robiou-du-Pont S., et al. The thorough screening of the MUTYH gene in a large French cohort of sporadic colorectal cancers. Genet Test 11 (2007) 373-379
61. Peterlongo P., Mitra N., Chuai S., et al. Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH. Int J Cancer 114 (2005) 505-507
62. Nielsen M., Hes F.J., Nagengast F.M., et al. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet 71 (2007) 427-433
63. Vasen H.F.A., Möslein G., Alonso A., et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57 (2008) 704-713